229 related articles for article (PubMed ID: 31991801)
1. Structural Diversity of Sense and Antisense RNA Hexanucleotide Repeats Associated with ALS and FTLD.
Božič T; Zalar M; Rogelj B; Plavec J; Šket P
Molecules; 2020 Jan; 25(3):. PubMed ID: 31991801
[TBL] [Abstract][Full Text] [Related]
2. ALS and FTD linked GGGGCC-repeat containing DNA oligonucleotide folds into two distinct G-quadruplexes.
Brčić J; Plavec J
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1237-1245. PubMed ID: 27856299
[TBL] [Abstract][Full Text] [Related]
3. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia.
Zu T; Liu Y; Bañez-Coronel M; Reid T; Pletnikova O; Lewis J; Miller TM; Harms MB; Falchook AE; Subramony SH; Ostrow LW; Rothstein JD; Troncoso JC; Ranum LP
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4968-77. PubMed ID: 24248382
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of Neurodegeneration Related to
Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
[TBL] [Abstract][Full Text] [Related]
5. Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD.
Zhou B; Liu C; Geng Y; Zhu G
Sci Rep; 2015 Nov; 5():16673. PubMed ID: 26564809
[TBL] [Abstract][Full Text] [Related]
6. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
Lagier-Tourenne C; Baughn M; Rigo F; Sun S; Liu P; Li HR; Jiang J; Watt AT; Chun S; Katz M; Qiu J; Sun Y; Ling SC; Zhu Q; Polymenidou M; Drenner K; Artates JW; McAlonis-Downes M; Markmiller S; Hutt KR; Pizzo DP; Cady J; Harms MB; Baloh RH; Vandenberg SR; Yeo GW; Fu XD; Bennett CF; Cleveland DW; Ravits J
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4530-9. PubMed ID: 24170860
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseases.
Riboldi G; Zanetta C; Ranieri M; Nizzardo M; Simone C; Magri F; Bresolin N; Comi GP; Corti S
Mol Neurobiol; 2014 Dec; 50(3):721-32. PubMed ID: 24809691
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
9. Antisense RNA C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms a triplex-like structure and binds small synthetic ligand.
Błaszczyk L; Ryczek M; Das B; Mateja-Pluta M; Bejger M; Śliwiak J; Nakatani K; Kiliszek A
Nucleic Acids Res; 2024 Jun; 52(11):6707-6717. PubMed ID: 38738637
[TBL] [Abstract][Full Text] [Related]
10. NMR structure of a G-quadruplex formed by four d(G4C2) repeats: insights into structural polymorphism.
Brcic J; Plavec J
Nucleic Acids Res; 2018 Nov; 46(21):11605-11617. PubMed ID: 30277522
[TBL] [Abstract][Full Text] [Related]
11. Anti-sense DNA d(GGCCCC)n expansions in C9ORF72 form i-motifs and protonated hairpins.
Kovanda A; Zalar M; Šket P; Plavec J; Rogelj B
Sci Rep; 2015 Dec; 5():17944. PubMed ID: 26632347
[TBL] [Abstract][Full Text] [Related]
12. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.
Donnelly CJ; Zhang PW; Pham JT; Haeusler AR; Mistry NA; Vidensky S; Daley EL; Poth EM; Hoover B; Fines DM; Maragakis N; Tienari PJ; Petrucelli L; Traynor BJ; Wang J; Rigo F; Bennett CF; Blackshaw S; Sattler R; Rothstein JD
Neuron; 2013 Oct; 80(2):415-28. PubMed ID: 24139042
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of parallel G-quadruplex formed by the two-repeat ALS- and FTD-related GGGGCC sequence.
Geng Y; Liu C; Cai Q; Luo Z; Miao H; Shi X; Xu N; Fung CP; Choy TT; Yan B; Li N; Qian P; Zhou B; Zhu G
Nucleic Acids Res; 2021 Jun; 49(10):5881-5890. PubMed ID: 34048588
[TBL] [Abstract][Full Text] [Related]
14. The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures.
Reddy K; Zamiri B; Stanley SYR; Macgregor RB; Pearson CE
J Biol Chem; 2013 Apr; 288(14):9860-9866. PubMed ID: 23423380
[TBL] [Abstract][Full Text] [Related]
15. The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD/ALS.
Kawabe Y; Mori K; Yamashita T; Gotoh S; Ikeda M
EMBO J; 2020 Oct; 39(19):e102700. PubMed ID: 32830871
[TBL] [Abstract][Full Text] [Related]
16. Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders.
Mis MSC; Brajkovic S; Tafuri F; Bresolin N; Comi GP; Corti S
Mol Neurobiol; 2017 Aug; 54(6):4466-4476. PubMed ID: 27349438
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic and spectroscopic investigations of TMPyP4 association with guanine- and cytosine-rich DNA and RNA repeats of C9orf72.
Alniss H; Zamiri B; Khalaj M; Pearson CE; Macgregor RB
Biochem Biophys Res Commun; 2018 Jan; 495(4):2410-2417. PubMed ID: 29274339
[TBL] [Abstract][Full Text] [Related]
18. G
Rothstein JD; Baskerville V; Rapuri S; Mehlhop E; Jafar-Nejad P; Rigo F; Bennett F; Mizielinska S; Isaacs A; Coyne AN
Acta Neuropathol; 2023 Nov; 147(1):1. PubMed ID: 38019311
[TBL] [Abstract][Full Text] [Related]
19. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Vatovec S; Kovanda A; Rogelj B
Neurobiol Aging; 2014 Oct; 35(10):2421.e1-2421.e12. PubMed ID: 24836899
[TBL] [Abstract][Full Text] [Related]
20. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
